ACE2 and COVID-19: Four studies reported extreme AKI rate of either 100% or less than 1% (2 COVID-19 studies and 2 studies which examined ACE2-associated viruses).28,84,110,112 Sensitivity analysis which excluded these studies did not alter our conclusion for the comparisons between the 3 viruses.